Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coave Therapeutics

www.coavetx.com

Latest From Coave Therapeutics

USANA ‘Cautiously Optimistic’ For Sales Rebound In 30th Year Despite Disappointing End To 2021

For its 2021 FY and Q4 results, nutritional and weight loss products direct seller reports lower gross margin and marketing expenses also contributed to lower-than-expected diluted EPS, down 45% to 18 cents.

Dietary Supplements Coronavirus COVID-19

Deal Watch: Appili Gets AiPharma’s Help In Advancing COVID-19 Therapy

Appili brings in AiPharma to help with US/Canadian development of Fujifilm’s potential COVID-19 preventative/therapeutic. Other recent tie-ups include CinFina/Janssen, Bone/Impant, Bayer/Gubra, Novartis/Theragnostics, Grifols/Biotest and more.

Deal Watch Business Strategies

Finance Watch: $135m In Venture Capital Will Fund Amylyx’s Late-Stage ALS Drug

Private Company Edition: Amylyx will use its new cash to run a Phase III trial and submit applications seeking EU and Canadian approvals of AMX0035, but US filing plans based on prior Phase II/III data are less clear. Also, three VC firms raised new funds targeting biopharma and other investments.

Financing Innovation

Renamed Coave Therapeutics Raises $39m To Fund Its Next-Gen Gene Therapies

The company aims to overcome drawbacks of existing gene therapy platforms, starting in ocular and CNS diseases.

Commercial Companies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Other Names / Subsidiaries
    • HORAMA S.A.
UsernamePublicRestriction

Register